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The DQw7 allele at the HLA-DQB locus is associated with susceptibility
to IgA nephropathy in Caucasians. The frequencies of the MHC class II
HLA-DR and DQ alleles in 36 Caucasian patients with IgA nephropathy
(IgAN) were analyzed by RFLP analysis and allele specific oligonucle-
otide (ASO) probing of specifically amplified genomic DNA. The class
II alleles HLA-DR4 (52.7%) and DR5 (30.5%) were increased in the
patient group compared to 1103 UK Caucasoid controls, but these
increases were not statistically significant. However, there was a
significant increase in the HLA-DQw7 allele frequency (7 1%) (c =
27.8%, x2 = 29.2, P < 0.001, Relative Risk = 6.17). This can be
explained by linkage disequilibrium between the DQw7 allele at the
DQB 1 locus and DRB 1 genes of some DR4 and all DR5 haplotypes. The
polymorphic portion of the DQa chains from DR4, DQw7 and DR5,
DQw7 haplotypes differ but they have identical DQ/3 chains. DNA
encoding DQw7 allele at the DQB I locus was sequenced in two patients
and was identical to that previously published. We conclude that the
DQw7 allele at the DQB I locus is strongly associated with susceptibility
to IgAN in Caucasians.
Mesangial IgA nephropathy (IgAN) is probably the most
common cause of chronic glomerulonephritis in the world [1]. It
affects all racial groups, though possibly with different frequen-
cies, and is characterized by focal proliferative nephritis asso-
ciated with mesangial deposits of IgA and often IgG. Neither
the etiology nor the pathogenesis are known but there appears
to be a generalized disturbance of immunoglobulin synthesis.
Many patients, and some of their relatives, have increased
concentrations of serum IgA, as well as hyper-responsiveness
to immunization with various antigens. The patients have
increased numbers of IgA secreting cells, and some also have
increased concentrations of macromolecular IgA which may in
part be in the form of immune complexes [2—41. Recently, a
number of autoantibodies have been reported in patients with
IgAN, including some that bind to mesangial cells. The concen-
tration of anti-mesangial cell antibodies varies with disease
activity which has led to the suggestion that they may be
pathogenic [51.
Familial IgAN is well documented, but most interest in the
genetical aspects of this condition has concentrated on the
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possible involvement of major histocompatibility complex
(MHC) antigens. The frequency of the MHC class II antigen
HLA-DR4 is increased in Japanese patients with IgAN; it is
present in 58 to 66% of patients, and 30 to 40% of normal
controls [6—81. Although an early study suggested that HLA-
DR4 might also be associated with IgAN in European Cauca-
soids [9], this has not been confirmed [4, 10—17]. One explana-
tion is that HLA-DR4 does not itself confer susceptibility, but is
closely linked to a susceptibility gene in the Japanese popula-
tion, but not in Caucasoids.
The genes which encode HLA class II molecules are located
within the MHC class II region on the short arm of chromosome
6. Three class II products DP, DQ and DR are expressed and
are crucial for presentation of processed antigen to specific T
cells. Each class II antigen is a heterodimer consisting of an a
and a /3 chain which are encoded by A and B genes respectively.
There is considerable linkage disequilibrium between the DR
and DQ loci, which means that certain DQ alleles are inherited
together with particular DR alleles more frequently than would
be expected by chance. This raises the possibility that IgAN is
primarily associated with DQ rather than DR genes. Class II
gene products are highly polymorphic. These polymorphisms
result largely from differences in the /3 chains but can also be
due to allelic differences in the DQa and DPa chains, which
show less variation than their respective /3 chains; the DRa
chain is not polymorphic.
Recent advances in the genetic analysis of the HLA system
have facilitated the detailed study of class II genes and their
association with autoimmune diseases. Such studies have re-
vealed even greater polymorphism within this region than was
apparent serologically, or using the mixed lymphocyte reaction.
Bidwell et al have pioneered the technique of allogenotyping
whereby cDNA probes for DRB, DQB and DQA genes are used
in RFLP analysis to define genetic polymorphism at these loci
[18—20]. Using these techniques it is possible to distinguish the
influence of DR and DQ genes separately.
The principle purpose of this study was to define the frequen-
cies of HLA-DR and DQ genes in Caucasoid patients with
IgAN and in particular, to determine whether a particular DQ
gene was associated with susceptibility. The results suggest that
the HLA-DQw7 allele at the DQBI locus is associated with
susceptibility to IgAN in Caucasoids.
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Methods
Patients
Thirty-six unrelated British Caucasoid patients, recruited
from Leicester General hospital, who were diagnosed with
primary IgA nephropathy were studied. IgAN was defined as
the presence of predominantly IgA deposits in the mesangium,
together with focal proliferative nephritis on renal biopsy.
There was no clinical or serological evidence of systemic lupus
erythematosus, Henoch Schönlein purpura or hepatic disease.
RFLP analysis
Genomic DNA was extracted from peripheral blood leuko-
cytes of all 36 patients by standard techniques. Ten sg of this
DNA was digested to completion with the restriction endonu-
clease TaqI (Northumbria Biological Ltd., England, UK). Frag-
ments were separated by gel electrophoresis in 0.8% agarose
gels, denatured and transferred to nylon membranes (Hybond
N, Amersham, UK) using the method described by Southern
[211. The membranes were hybridized sequentially with radio-
labelled eDNA probes to the DRB, DQB and DQA genes. For
each hybridization 50 ng of cDNA probe was radiolabelled with
32Pa-dCTP using the random primer method. Membranes were
washed at high stringency: two 10-minute washes at room
temperature with 2 x SSC(1 X SSC = 0.15 M NaCI, 0.015 M Na
citrate), 0.1% SDS (sodium dodecyl sulphate) followed by 0.2 x
SSC, 0.1% SDS at 65°C for 40 minutes. The membranes were
exposed to Kodak XAR5 film in the presence of two intensify-
ing screens at —70°C for three to five days. Following each
probing the membranes were stripped using boiling 0.1% SDS
and stored, moist, prior to reprobing. Allogenotypes were
assigned using the criteria enumerated by Bidwell et al [18]
(Table 1) and their frequencies compared with 1103 British
Caucasoid controls typed by the same methods (courtesy of Dr.
J. Bidwell, U.K. Transplant Service Bristol).
Class II probes
The following cDNA probes were used (1) a 520bp Pstl
fragment of the DR4 DRB I gene (including exons 3 and 4)
inserted into the plasmid pBR322, (2) a 940bp EcoRl fragment
of the DQB 1 gene of a DR4, DQw7 individual inserted into
pBR322, and (3) a 1.3 Kb EcoRl fragment of the DQA1 gene of
a DR4, DQA3 individual inserted into the puc9 vector.
DNA amplification by polymerase chain reaction
The polymerase chain reaction (PCR) was used to amplify a
specific segment of the DQB gene, which encodes the first
domain of the DQ/3 chain, in 29 patients [221 and in two control
individuals whose DQB genotypes (DQw7 and DQw8) had
previously been confirmed by nucleotide sequencing. The PCR
reaction was initiated using the following synthetic oligonucle-
otide primers which were designed using previously published
sequences of DQB1 genes: 5'-ATCGAATTCCAGAGGATT-
TCGTGTAC-3', for the forward reaction, 5'-AACGTCGC-
CGCCCACTGACGTCGAT-3' for the reverse reaction. An-
nealing was performed at 45°C for two minutes, denaturation at
94°C for two minutes and extension at 72°C for two minutes. A
total of 30 cycles was performed.
Table 1. Allogenotypes a1' 36 patients with IgAN
Patient DRB DQA DR
DQw7
ASO
type DQC
65
66
67
68
69
70
71
72
73
74
75
76
77
79
81
82
93
94
95
96
97
98
99
100
101
102
l03
104
105
106
107
108
109
110
111
112
7(2),l3b
4,4
4,4
9,5(11)
2,2
1,4
4,13a(3)
4,l3a(3)
5(ll),4
4,8
1,4
2,4
2,5(11)
5(11),13b
4,4
1,1
4,5(12)
13a(4),3(1)
4,5(11)
3(2),13a(4)
4,4
4,10
4,7(1)
4,13a(3)
7(1),7(2)/9
2,4
7(l),7(2)
2,5(11)
4,4
2,5(11)
14a,13b
4,1
2,10
1,5(12)
3(1),5(11)
1,5(12)
3,2
3,3
3,3
3,3
lb,lb
la,3
3,la
3,la
2,3
3,lb
la,3
lb,3
lb,lc
2,2
3,3
la,la
nd
lc,2
2,3
lc,2
nd
nd
3,3
3,lb
nd
lb,3
lc,3
lb,2
3,3
lab
la,2
1a,3
la,lb
Ia,2
nd
la,2
7,6
4,4
4,4
9,5
2,2
1,4
4,6
4,6
5,4
4,8
1,4
2,4
2,5
5,6
4,4
1,1
4,5
6,3
4,5
3,6
4,4
4,10
4,7
4,6
7,7(2)/9
2,4
7,7
2,5
4,4
2,5
6,6
4,1
2,10
1,5
3,5
1,5
+
—
—
+
nd
+
+
—
nd
+
—
+
nd
+
+
nd
+
—
+
nd
+
+
+
+
nd
+
+
+
+
+
+
+
nd
+
+
+
w2,w7
w8,w8
w8,w8
w8,w7
w6,w6
w5,w7
w7,w5
w8,w5
w7,w8
w8,w7
w5,w8
w6,w7
w5,w7
w7,w7
w7,w7
w5,w5
w8,w7
w6,w2
w8,w7
w2,w6
w7,w7
W7,b
w7,w2
w7,w5
nd
w6,w7
w2,w7
w6,w7
w7,w7
w5,w7
w5,w7
w7,w5
w5,w6
w5,w7
w2,w7
w5,w7
Abbreviation is nd, not done.
a Only patient whose inferred haplotype was not seen in the 1103
control patients
b Unable to assign second allele
° Based on RFLP and ASO typing
Allele specific oligonucleotide probing
One tenth of the amplified DNA from the PCR reaction was
electrophoresed in 1.0% agarose gels, denatured, neutralized
and transferred to nylon membranes. The filters were probed in
an identical manner to the Southern blots (using the DQB
probe) to confirm the presence of the PCR product, and to
quantify it. The blots were stripped with boiling 0.1% SDS and
autoradiographed overnight at —70°C to ensure complete strip-
ping prior to probing with the DQw7 allele specific oligonucle-
otide (ASO) probe. The sequence of the DQw7 specific ASO
used is as follows: 5'-TTGCGUATGTGACCAGATAC-3'
[23]. Hybridization temperature was 53°C (5°C less than the
temperature of dissociation of the probe). The hybridization
buffer was S x SSPE (1 x SSPE = 0.18 M NaCl, 0.01 M
Na2HPO4, pH 7.7 and 1 m EDTA) in 2% SDS containing 50
g/ml salmon sperm DNA. This was used to prehybndize the
blots for at least one hour before the addition of the radiola-
belied DQw7 ASO probe. The radiolabelled ASO was added to
give 0.5 x 106 counts/nil of hybridization fluid and were end
Fragment
size ft
6.9 —s
Patient number
65 66 68 70 74 75 77
'p
me
seS
5.4 —
4,2 ——*
3.0
2.3 —'S
1.9 —k
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Table 2. Frequency of HLA-DR and -DQ antigens in IgA
nephropathy patients and controls
Controls
Allele
Patients
% (N)
N = 1103
%
DR N = 36
1 13.8 (5) 20.7
2 (wl5,16) 19.4 (7) 31.3
3 (w17,w18) 8.3 (3) 21.8
4 52.7 (19) 36.9a
5 (wll,w12) 30.5 (12) 12.9°
6 (w13,w14) 19.4 (7) 25.6
7 13.8 (5) 24.2
8 2.7 (1) 5.4
9 2.7 (1) 2.2
10 5.5 (2) 1.5
DQB N = 35
w5 37.1 (13) 27.9
w6 20 (7) 43.3
w2 17 (6) 36
w7 71(25) 278b
w8 25.7 (9) 30
DQA N 31
la 35.5 (11) 27.9
lb 19.3 (6) 43.3
ic 12.9(4) 11.3
2 32.2 (10) 36.6
3 61.2 (19) 63.3
Not significantb
= 29.2, Pc = <<<0.001, RR = 6.17
labelled with 32P dATP using T4 DNA kinase. The blots were
washed to a stringency of 2 x SSC at 58°C (1°C less than the
temperature of dissociation) and exposed to Kodak XAR 5 film
at —70°C.
Nucleotide sequencing
The accuracy of ASO typing was determined by cloning the
amplified DQB gene segments into Ml 3 vectors and obtaining
nucleotide sequence by the modified dideoxy sequencing
method of Sanger et al [24]. The derived amino acid sequences
were then compared with those previously published [25—271.
Quantflcation and statistics
The significance of association was tested using the Chi
square test. The probability of an association was corrected for
the number of comparisons made by multiplying the P values
obtained by 24 which is the number of different haplotypes in
the control group of 1103 British Caucasoids. Relative Risks
(RR) were calculated using standard formulae [28].
Results
Allo genotype frequencies
The RFLPs generated using the DRB, DQA and DQB probes
on Taql digested genomic DNA allowed the DR alleles to be
identified in all 36 patients with IgAN, and thus, the frequency
of the particular expressed DR molecules to be inferred. The
frequencies of both the DR4 and DR5 alleles were increased
(52.7% compared with 36.9% for DR4, and 30.5% vs. 12.9% for
DR5); in neither case did the results reach statistical signifi-
cance when corrected for the number of comparisons made. All
the other DR alleles occurred less frequently than in the control
Fig. 1. Southern blot of genomic DNA prepared from 7 Caucasoid
patients with IgAN. DNA has been digested with the restriction enzyme
Taql and probed with a radiolabelled cDNA probe to the DQB gene.
DQB allogenotypes assigned to each patient are shown in Table 1. The
difficulties in identifying DQw7 positive individuals is illustrated; pa-
tient No. 65 was found to be DQw7 positive by ASO typing, yet the 2.0
Kb RFLP band which is characteristic of this allogenotype was faint. In
addition, the double band at 4.2 Kb seen in patient No. 74 who was also
shown to have the DQw7 allogenotype by ASO typing was not clearly
visible. Patients 66 and 68 can be seen to have very similar RFLP
patterns yet the former is DQw7 negative by RFLP and the latter is
positive.
group (Table 2). The DQA alleles were identified by RFLP in 31
of the 36 patients using the DQA probe and there were no
differences in the frequencies found in patients versus controls
(Table 2).
It was not possible to identify all the DQB alleles using RFLP
analysis alone as it proved difficult to distinguish accurately
between the RFLPs generated by the DQw7 and DQw8 alleles
at the DQB1 locus (Fig. 1). Using the Taql restriction enzyme
and the DQB gene probe, the DQw7 allele is characterized by a
double band at 4.2 Kb and a single 2.0 Kb band. In our hands
the second band at 4.2 Kb was sometimes very faint and the 1.9
Kb band was often absent. DNA from all patients who inherited
either DQw7 or DQw8 by RFLP was analyzed further using an
ASO probe (Fig. 2). The results from the combined use of the
RFLP analysis and the ASO probing are shown in Table 1.
There was a significant increase in the frequency of the DQw7
allele at the DQB 1 locus; it was found in 71% of the IgAN
patients compared with 29% of the controls ( = 29.2, P °
0.001, RR = 6.17). We were able to infer both haplotypes in all
but one of the patients based on the combination of DR and DQ
Fig. 2. Southern blots of DQB gene segments
from 9 patients and 2 controls which have been
ampljfied by the PCR. The allogenotypes of the
control samples had previously been confirmed
by nucleotide sequencing. Samples labeled 1—9
were amplified from genomic DNA from patients
65, 66, 79, 68, 70, 71, 67, 72, 94 respectively. The
HLA-DR and -DQ allogenotypes of these patients
are shown in Table 1. The upper row shows
hybridization of the amplified DNA with the
DQB gene probe. The lower row shows the same
filters reprobed with the DQw7 specific ASO and
washed to a high stringency so that the probe
remains bound only to the DQw7 positive
controls and to amplified DNA samples of
identica' sequence.
alleles which they inherited. All the common DQw7 bearing
haplotypes contributed to the increased frequency of DQw7.
In normal Caucasoid populations, 33% of DR4 positive
individuals inherit DQw7 whereas 67% inherit DQw8. This
demonstrates that significantly more HLA-DR4 IgAN patients
had inherited DQw7 (57.9%) than HLA-DR4 controls (33%) (y
DNA sequencing
The DNA encoding the first domain of the DQI31 chains was
sequenced from two patients, identified as DQw7 by ASO
probing. This was done to test the validity of the typing
procedures and to confirm that the gene segment had normal
nucleotide sequence. The results confirmed that genomic DNA
from both patients contained the normal DQw7 nucleotide
sequence.
Discussion
The HLA complex has a powerful influence on susceptibility
to autoimmune and immuno-inflammatory diseases, including
various types of glomerulonephritis. Studies in different racial
groups have shown that diseases associated with particular
MHC alleles in one racial group commonly have equally strong
HLA associations in other racial groups, although the alleles
involved may be different. IgAN is unusual, in that, it has been
consistently associated with HLA-DR4 in Japanese patients,
but despite numerous studies in European Caucasoids, an
association with HLA-DR4 was only found in two French
groups of patients. All other studies have failed to show any
significant association with HLA class II alleles. The data
presented here suggest that this paradox can be resolved
because it demonstrates a strong association between IgAN and
the HLA-DQBI locus.
It is difficult to analyze associations between HLA genes and
disease because natural segregation ratios are distorted by
linkage disequilibrium. This means that within a given racial
group, particular HLA-DR genes are almost invariably inher-
ited together with particular HLA-DQ genes. In fact, the
linkage disequilibrium extends much further to involve MHC
class I and class III genes in so called "extended haplotypes".
Thus, it may be impossible to distinguish between the effects of
the susceptibility gene itself and those of genes at closely linked
loci. Analysis of the MHC using molecular biological tech-
niques has considerably simplified this problem since it allows
the separate study of genes at closely linked loci in a way not
possible by serology.
Our study of HLA class II genes in IgAN detected an
increase in the frequency of both the DRB 1 genes which
determine DR4 and DR5 types. Like previous studies of DR
antigens in European Caucasoids, neither increase reached
statistical significance. However, we found a significant in-
crease in the frequency of DQw7 which was presentin 71% of
the IgAN patients compared with 28% of controls; ( = 29.2,
P 0.001, RR = 6.17). The presence of DQw7, which was first
suggested by RFLP analysis, was confirmed using an allele
specific DQw7 probe and directly by nucleotide sequencing in
two patients.
The involvement of the DQB 1 locus in susceptibility to IgAN
has previously been suggested by Moore et a! who, using a
different DQB probe and less stringent washes to probe Taql
digested genomic DNA found a highly significant increase in a
particular DQB RFLP pattern. They reported a significantly
increased frequency of 2 Taql fragments (IgAN, 49% vs.
controls, 15% P < 0.001) in their patient group. These frag-
ments, designated T2 and T6 after their respective 2 Kb and 6
Kb sizes, could not be attributed confidently to specific DQB
alleles [29]. The same group had previously shown a similar
pattern to be associated with DR4 and to be increased in
frequency in diabetic patients who had inherited DR4. Thus,
Moore proposed that IgAN and IDDM shared an association
with the same DQB gene, which in the case of diabetes has been
shown to be DQw8. Our data make this interpretation very
unlikely but suggests that, like us, Moore et al were unable to
distinguish accurately between DQw7 and DQw8 by RFLP
analysis alone. Our results from ASO probing and nucleotide
sequencing clearly showed that the frequency of the DQw7
allele at the DQB 1 locus was increased whereas that of the
DQw8 allele was normal.
The observation that the increased frequency of DQw7 is
independent of which DRB or DQA genes are inherited sug-
gests that the DQBI locus itself, or alternatively a locus
centromeric to it, influences susceptibility. This would exclude
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= 4.4).
Patients
1 2 3 4 5 6 7 8 9 controls
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DQw7ASO •
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a role for particular C2 and C4 complement allotypes as an
explanation for our findings, even though they lie within the
MHC complex, and there have been tentative suggestions that
C4 genes contribute to susceptibility [301. Transracial studies of
the HLA-DQB alleles in IgAN should resolve the issue of
whether DQB1 is a true susceptibility locus by exploiting
variations in linkage disequilibrium found in different racial
groups. Such studies are currently underway in our laboratory.
In summary, we have identified a strong association between
IgAN and the HLA-DQBw7 allele and suggest that this is a
determinant of genetic susceptibility to IgAN.
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